Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Total Liabilities (2022 - 2025)

Neuraxis' Total Liabilities history spans 4 years, with the latest figure at $3.5 million for Q3 2025.

  • For Q3 2025, Total Liabilities rose 18.87% year-over-year to $3.5 million; the TTM value through Sep 2025 reached $3.5 million, up 18.87%, while the annual FY2024 figure was $2.7 million, 40.63% up from the prior year.
  • Total Liabilities for Q3 2025 was $3.5 million at Neuraxis, up from $2.8 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $11.5 million in Q2 2023 and bottomed at $1.9 million in Q4 2023.
  • The 4-year median for Total Liabilities is $3.5 million (2022), against an average of $4.7 million.
  • The largest YoY upside for Total Liabilities was 230.41% in 2023 against a maximum downside of 72.89% in 2023.
  • A 4-year view of Total Liabilities shows it stood at $7.1 million in 2022, then tumbled by 72.89% to $1.9 million in 2023, then soared by 40.63% to $2.7 million in 2024, then rose by 29.8% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Total Liabilities are $3.5 million (Q3 2025), $2.8 million (Q2 2025), and $2.8 million (Q1 2025).